A- A A+
Last Updated : Aug 5 2021 10:45PM     Screen Reader Access
News Highlights
India's ace grappler Ravi kumar Dahiya creates history, clinches Silver Medal; Men's Hockey team snatch Bronze medal            Both houses of Parliament witness repeated adjournments over Pegasus issue and Farm Bills; adjourned for the day            PM Modi interacts with the beneficiaries of Pradhan Mantri Garib Kalyan Anna Yojana in Uttar Pradesh            India crosses another milestone in COVID-19 Vaccination Drive, crosses 49 Cr mark; recovery rate stands at 97.37%            Bombay HC asks Maha govt to consider issuing vaccination card to allow fully inoculated people to travel in local trains           

National News

May 29, 2021
8:13AM

Centre in regular touch with national and international manufacturers to augment availability of Corona vaccines

REPRESENTATIONAL IMAGE
The Union Health Ministry has said that the government of India is doing regular interaction with national and international vaccine manufacturers like Pfizer and Moderna to make more COVID-19 vaccines available in the country. The Health Ministry said that the  concrete actions are a stern indication that the Government is making all efforts to increase the vaccine production in the country as well as attracting the foreign vaccine manufacturers to supply the required vaccine doses for the national covid vaccination programme. It said, as of date, India is using three vaccines against COVID-19 in its immunization drive. It includes two made in India vaccines - Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin who have supplied about 7.92 crore vaccine doses in the month of May 2021.

The Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for restricted use in emergency situations and is being used in a few private hospitals which are expected to be increased over the coming days.

It said, despite the constraints of availability, India has fared well in covering 20 crore people in only 130 days which is the third largest coverage in the world.

The Ministry further added that the manufacturing capacities have been ramped up and vaccines being a biological product takes time for harvesting and quality testing. This cannot be done overnight to ensure a safe product. Thus, the increase in capacity of manufacturing too needs to be a guided process.

It said, National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) was already established in August 2020 to provide guidance on all aspects of vaccine introduction including prioritization of beneficiaries, procurement, vaccine selection and its delivery.

The Central Government has been supporting the efforts of States and Union Territories for effective management of COVID patients in vaccination, under the ‘Whole of Government” approach since January this year.

Live Twitter Feed

Listen News

Morning News 5 (Aug) Midday News 5 (Aug) Evening News 5 (Aug) Hourly 5 (Aug) (1910hrs)
समाचार प्रभात 5 (Aug) दोपहर समाचार 5 (Aug) समाचार संध्या 5 (Aug) प्रति घंटा समाचार 5 (Aug) (2200hrs)
Khabarnama (Mor) 5 (Aug) Khabrein(Day) 5 (Aug) Khabrein(Eve) 5 (Aug)
Aaj Savere 5 (Aug) Parikrama 5 (Aug)

Listen Programs

Market Mantra 5 (Aug) Samayki 1 (Jan) Sports Scan 5 (Aug) Spotlight/News Analysis 5 (Aug) Employment News 5 (Aug) रोजगार समाचार 5 (Aug) World News 4 (Aug) Samachar Darshan 22 (Mar) Radio Newsreel 21 (Mar)
    Public Speak

    Country wide 12 (Mar) Surkhiyon Mein 5 (Aug) Charcha Ka Vishai Ha 11 (Mar) Vaad-Samvaad 17 (Mar) Money Talk 17 (Mar) Current Affairs 6 (Mar) Sanskrit Saptahiki 31 (Jul) North East Diary 5 (Aug)